Archive for the ‘elsevier’ Category
Journal retracts nine papers in one day by author under investigation at the Weizmann Institute
On April 27, the Journal of Biological Chemistry (JBC) retracted nine papers by a researcher based in Israel, including some dating back to 2000.
The reason: Image manipulation.
Michal Neeman, vice president of The Weizmann Institute of Science, told us that the researcher, Rony Seger, is under investigation following an allegation of misconduct affecting papers in multiple journals.
So far, we’ve found 11 retractions for papers by Seger, a molecular biologist. In the notices, the authors state they have “full confidence” in the findings, and in many instances have replicated the work.
According to Neeman:
Journal retracts paper eight months after U.S. Feds announce findings of misconduct
In August, the U.S. Office of Research Integrity announced that a former postdoctoral fellow at the National Human Genome Research Institute (NHGRI) doctored data in two published papers.
It took one journal a little longer than five months to remove the researcher’s name from the co-author list, and replace one figure.
It took the second journal more than eight months to retract the paper.
Here’s the notice for “A BLOC-1 Mutation Screen Reveals that PLDN Is Mutated in Hermansky-Pudlak Syndrome Type 9,” published by the American Journal of Human Genetics (AJHG):
Despite author’s protest, journal removes paper on emergency department prices
A journal has temporarily removed a paper showing the dramatic differences in the cost of providing emergency care that caught national attention (and some criticism from emergency care providers), despite the first author’s claims that the results are valid.
The paper, published online in February by the Annals of Emergency Medicine, showed that it can cost significantly more for patients to be treated at emergency departments than at urgent care centers, even for the same conditions. Soon after the paper was published, first author Vivian Ho at Rice University was told by the American College of Emergency Physicians, which publishes the journal, that there were some errors in the appendix, and they wanted to reanalyze the entire paper.
Ho told us:
A university asked for numerous retractions. Eight months later, three journals have done nothing.
Anil Jaiswal
When journals learn papers are problematic, how long does it take them to act?
We recently had a chance to find out as part of our continuing coverage of the case of Anil Jaiswal at the University of Maryland, who’s retracted 15 papers (including two new ones we recently identified), and has transitioned out of cancer research. Here’s what happened.
As part of a public records request related to the investigation, we received letters that the University of Maryland sent to 11 journals regarding 26 “compromised” papers co-authored by Jaiswal, four of which had been retracted by the time of the letter. The letters were dated between August and September 2016 (and one in February) — although, in some cases, the journals told us they received the letter later. Since that date, three journals have retracted nine papers and corrected another, waiting between four and six months to take action. One journal published an editorial note of concern within approximately two months after the university letter.
And six journals have not taken any public action.
A shadow was cast on a bone researcher’s work. What are journals doing about his papers?
Last year, a researcher cast doubt on a bone scientist’s clinical trials, suggesting some of the findings may not be legitimate. So what’s happened since?
Since 2015, journals have retracted 14 papers by bone researcher Yoshihiro Sato, based at Mitate Hospital in Japan, for issues ranging from self-plagiarism, to problems with data, to including co-authors without their consent. (We covered the latest two retractions this week.) Last year’s analysis identified patterns in more than 30 of Sato’s clinical trials that suggest systematic problems with the results. (Sato has defended his research.)
With doubts cast on Sato’s body of work, we contacted the journals that have published his papers involving human trials, to see if any taken another look at Sato’s work; several responded. While most believe there is little reason to take further action at this time, some told us they are investigating.
Read the rest of this entry »
Prominent physicist loses four more papers for duplication
A leading physicist in India has lost four more papers for duplication, after colleagues lodged a complaint against him.
According to the most recent retraction notices, issued by Applied Surface Science, the four papers duplicated several figures and portions of text from the authors’ previous works. Although the notices do not single out a responsible party, last year the Mumbai Mirror reported that first and corresponding Naba K. Sahoo had been accused of duplication by colleagues at the Bhabha Atomic Research Centre (BARC), part of Indian government’s Department of Atomic Energy.
(In a bizarre twist, Sahoo also made the news recently for getting into a fist fight with another BARC scientist.)
Sahoo received two retractions last year for duplication, sometimes inelegantly referred to as “self-plagiarism.” All six of his retractions affect papers published by Applied Surface Science between 2005 and 2007.
The first retraction notice explains that a 2006 paper lifted portions of text from an earlier paper by Sahoo: Read the rest of this entry »
Busted: Researcher used fake contact info for co-authors
In February, Lusine Abrahamyan, an assistant professor at the University of Toronto, was contacted by ResearchGate. Her name was listed on a 2016 paper in a heart journal, the site told her — was Abrahamyan indeed a co-author?
Um, no, she was not. In fact, before that moment, she didn’t know such a paper existed.
It turns out, Abrahamyan had supervised the thesis of the first author — who, she soon learned, had also published an identical paper in another heart journal. Both have since been retracted.
How did this happen?
International Cardiovascular Forum Journal editor Andrew Coats told us more about the actions of first author Joshua Chadwick Jayaraj: Read the rest of this entry »
Idea theft: Two food chemistry papers retracted for using someone’s ideas
A researcher has retracted two papers after her former supervisor complained she had used his ideas and methodology.
In addition, some of the work was apparently covered by a copyright agreement.
Both papers were co-authored by the same three people. The idea theft came to light after one of the co-authors received a complaint from her former supervisor, prompting her to contact the publisher to resolve the issue.
Wendy Hurp, executive publisher of Food Science at Elsevier, which publishes the two journals, provided some additional background on what happened: Read the rest of this entry »
Multiple OMICS journals delisted from major index over concerns
SCOPUS, the publication database maintained by Elsevier, has discontinued nearly 300 journals since 2013, including multiple journals published by OMICS Publishing Group.
Although the reasons the widely used database gives for discontinuing journals often vary, in all cases OMICS journals were removed over “Publication Concerns.”
Here’s what SCOPUS said recently about how it vets journals:
Macchiarini blames Karolinska for losing data as he retracts 2014 paper
Ask and ye shall receive: A journal has retracted a 2014 paper by Paolo Macchiarini, upon request from the Karolinska Institutet (KI).
The latest news is only one step in a long-running saga about former star surgeon Macchiarini, who was dismissed from KI last year. To read more, check out our timeline.
KI announced it was asking the journal to pull the paper late last year, after concluding that four authors — including Macchiarini — were guilty of scientific misconduct. The paper had already been flagged by the journal with an expression of concern, noting the data presented in the paper may not be “fully representative” of the experiments.
Today, the journal issued a retraction notice, saying the authors wanted to retract the paper. All of the authors who could be reached have agreed to the retraction, including Macchiarini.
Here’s more from the notice:
